All Stories

  1. Machine learning as a new tool in neurological disease prevention, diagnosis, and treatment

    Article • February 2023, Open Exploration Publishing

    Dr Cinzia Volonté

  2. Delineating Purinergic Signaling in Drosophila

    Article • International Journal of Molecular Sciences, December 2022, MDPI AG

    Dr Cinzia Volonté, Dr Francesco Liguori

  3. Rethinking purinergic concepts and updating the emerging role of P2X7 and P2X4 in amyotrophic lateral sclerosis

    Article • Neuropharmacology, December 2022, Elsevier

    Dr Cinzia Volonté

  4. Vitamin B6 rescues insulin resistance and glucose‐induced DNA damage caused by reduced activity of Drosophila PI3K

    Article • Journal of Cellular Physiology, June 2022, Wiley

    Dr Cinzia Volonté, Dr Francesco Liguori

  5. Repurposing Histaminergic Drugs in Multiple Sclerosis

    Article • International Journal of Molecular Sciences, June 2022, MDPI AG

    Dr Cinzia Volonté

  6. S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis

    Article • International Journal of Molecular Sciences, December 2021, MDPI AG

    Dr Cinzia Volonté

  7. Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model

    Article • International Journal of Molecular Sciences, September 2021, MDPI AG

    Dr Cinzia Volonté

  8. Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders

    Article • Neuroscience & Biobehavioral Reviews, August 2021, Elsevier

    Dr Cinzia Volonté

  9. Fly for ALS: Drosophila modeling on the route to amyotrophic lateral sclerosis modifiers

    Article • Cellular and Molecular Life Sciences, July 2021, Springer Science + Business Media

    Dr Cinzia Volonté, Dr Francesco Liguori

  10. Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis

    Article • Neurotherapeutics, May 2021, Springer Science + Business Media

    Dr Cinzia Volonté

  11. Where and Why Modeling Amyotrophic Lateral Sclerosis

    Article • International Journal of Molecular Sciences, April 2021, MDPI AG

    Dr Cinzia Volonté, Dr Francesco Liguori

  12. Activation of skeletal muscle–resident glial cells upon nerve injury

    Article • JCI Insight, April 2021, American Society for Clinical Investigation

    Dr Cinzia Volonté

  13. What strikes most when we think of Geoff

    Article • Purinergic Signalling, March 2021, Springer Science + Business Media

    Dr Cinzia Volonté

  14. P2X7 Receptor Agonist 2′(3′)-O-(4-Benzoylbenzoyl)ATP Differently Modulates Cell Viability and Corticostriatal Synaptic Transmission in Experimental Models of Huntington’s Disease

    Article • Frontiers in Pharmacology, February 2021, Frontiers

    Dr Cinzia Volonté, Dr Francesco Liguori

  15. Nerve Growth Factor Neutralization Promotes Oligodendrogenesis by Increasing miR-219a-5p Levels

    Article • Cells, February 2021, MDPI AG

    Dr Cinzia Volonté

  16. Functional Inactivation of Drosophila GCK Orthologs Causes Genomic Instability and Oxidative Stress in a Fly Model of MODY-2

    Article • International Journal of Molecular Sciences, January 2021, MDPI AG

    Dr Cinzia Volonté, Dr Francesco Liguori

  17. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Article • Autophagy, January 2021, Taylor & Francis

    MD, PhD Pierre-Louis Tharaux, Joilson O. Martins, Dr. rer. nat. Marc Herb, Dr Marcia R Cominetti, Alessio Di Fonzo, Christoph Gerhardt, Dr Mustafa Sahin, Dr Cinzia Volonté, Dr Marc Etienne Poirot, Professor Paula I. Moreira, Executive Director, The Hormel Institute Robert Clarke, Prof Robert Bryson-Richardson, Professor Hyun Kyu Song, Prof Claudia Cavadas, Professor Po Sing Leung, Paula Ludovico, Javeed Shah, Giovanni Di Guardo, Dr Takeshi Noda, Professor Tullio Florio, Professor Kevin Coombs, Ning Chen

  18. The Histamine and Multiple Sclerosis Alliance: Pleiotropic Actions and Functional Validation

    Article • January 2021, Springer Science + Business Media

    Dr Cinzia Volonté

  19. Omics-based exploration and functional validation of neurotrophic factors and histamine as therapeutic targets in ALS

    Article • Ageing Research Reviews, September 2020, Elsevier

    Dr Cinzia Volonté

  20. Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis

    Article • Frontiers in Pharmacology, July 2020, Frontiers

    Dr Cinzia Volonté, Dr Francesco Liguori

  21. P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance

    Article • Frontiers in Endocrinology, May 2020, Frontiers

    Dr Cinzia Volonté

  22. The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing—Remitting Multiple Sclerosis Mouse Model

    Article • Cells, March 2020, MDPI AG

    Dr Cinzia Volonté

  23. Functional microglia neurotransmitters in amyotrophic lateral sclerosis

    Article • Seminars in Cell and Developmental Biology, October 2019, Elsevier

    Dr Cinzia Volonté

  24. Histamine beyond its effects on allergy: Potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS)

    Article • Pharmacology & Therapeutics, October 2019, Elsevier

    Dr Cinzia Volonté

  25. Stimulation of P2X7 Enhances Whole Body Energy Metabolism in Mice

    Article • Frontiers in Cellular Neuroscience, August 2019, Frontiers

    Dr Cinzia Volonté

  26. P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis

    Article • Brain Pathology, August 2019, Wiley

    Dr Cinzia Volonté

  27. Histamine Is an Inducer of the Heat Shock Response in SOD1-G93A Models of ALS

    Article • International Journal of Molecular Sciences, August 2019, MDPI AG

    Dr Cinzia Volonté

  28. Histaminergic transmission slows progression of amyotrophic lateral sclerosis

    Article • Journal of Cachexia Sarcopenia and Muscle, April 2019, Wiley

    Dr Cinzia Volonté

  29. Commentary: Stephen William Hawking (8 January 1942 - 14 March 2018)

    Article • CNS & Neurological Disorders - Drug Targets, June 2018, Bentham Science Publishers

    Dr Cinzia Volonté

  30. Micropatterned Geometry Shape Oligodendrocyte and Microglia Plasticity

    Article • December 2017, Springer Science + Business Media

    Dr Cinzia Volonté

  31. Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis

    Article • Frontiers in Immunology, November 2017, Frontiers

    Dr Cinzia Volonté

  32. Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis

    Article • Frontiers in Immunology, November 2017, Frontiers

    Dr Cinzia Volonté

  33. P2X7 Receptor Activation Modulates Autophagy in SOD1-G93A Mouse Microglia

    Article • Frontiers in Cellular Neuroscience, August 2017, Frontiers

    Dr Cinzia Volonté

  34. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression

    Article • Journal of Neuroinflammation, August 2016, Springer Science + Business Media

    Dr Cinzia Volonté

  35. Meet Our Editorial Board Member

    Article • CNS & Neurological Disorders - Drug Targets, August 2016, Bentham Science Publishers

    Dr Cinzia Volonté

  36. Purinergic contribution to amyotrophic lateral sclerosis

    Article • Neuropharmacology, May 2016, Elsevier

    Dr Cinzia Volonté

  37. M1 and M2 Functional Imprinting of Primary Microglia: Role of P2X7 Activation and miR-125b

    Article • Mediators of Inflammation, January 2016, Hindawi Publishing Corporation

    Dr Cinzia Volonté

  38. New Kid on the Block: Does Histamine Get Along with Inflammation in Amyotrophic Lateral Sclerosis?

    Article • CNS & Neurological Disorders - Drug Targets, May 2015, Bentham Science Publishers

    Dr Cinzia Volonté

  39. MicroRNAs: Newcomers into the ALS Picture

    Article • CNS & Neurological Disorders - Drug Targets, March 2015, Bentham Science Publishers

    Dr Cinzia Volonté

  40. Editorial (Thematic Issue: MiRNAcles in the Brain: What to Wish and What to Fear)

    Article • CNS & Neurological Disorders - Drug Targets, March 2015, Bentham Science Publishers

    STEPHEN SKAPER, Dr Cinzia Volonté

  41. Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis

    Article • Molecular Neurobiology, December 2014, Springer Science + Business Media

    Dr Cinzia Volonté

  42. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis

    Article • Disease Models & Mechanisms, July 2014, The Company of Biologists

    Dr Cinzia Volonté

  43. Commentary: (Research Highlights Inflammation, Demyelination and Neurodegeneration: Risky Buddies in Multiple Sclerosis)

    Article • CNS & Neurological Disorders - Drug Targets, February 2014, Bentham Science Publishers

    Dr Cinzia Volonté

  44. P2Y12Receptor on the Verge of a Neuroinflammatory Breakdown

    Article • Mediators of Inflammation, January 2014, Hindawi Publishing Corporation

    Dr Cinzia Volonté

  45. Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation

    Article • Cell Death and Disease, December 2013, Nature

    Dr Cinzia Volonté

  46. Commentary-1 Research Highlights (Never Underestimate the Power of Adenosine in Multiple Sclerosis)

    Article • CNS & Neurological Disorders - Drug Targets, November 2013, Bentham Science Publishers

    Dr Cinzia Volonté

  47. Commentary: Never Underestimate the Power of Adenosine in Multiple Sclerosis

    Article • CNS & Neurological Disorders - Drug Targets, September 2013, Bentham Science Publishers

    Dr Cinzia Volonté

  48. Commentary: (Research Highlights: “MiRNAcles” in Brain)

    Article • CNS & Neurological Disorders - Drug Targets, August 2013, Bentham Science Publishers

    Dr Cinzia Volonté

  49. Commentary (Brilliant Blue G: What a Little More Colour Can Be)

    Article • CNS & Neurological Disorders - Drug Targets, July 2013, Bentham Science Publishers

    Dr Cinzia Volonté

  50. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis

    Article • Human Molecular Genetics, June 2013, Oxford University Press (OUP)

    Dr Cinzia Volonté

  51. P2X3 receptor: a novel ‘CASKade’ of signaling?

    Article • Journal of Neurochemistry, May 2013, Wiley

    Dr Cinzia Volonté

  52. The NADPH Oxidase Pathway Is Dysregulated by the P2X7 Receptor in the SOD1-G93A Microglia Model of Amyotrophic Lateral Sclerosis

    Article • The Journal of Immunology, April 2013, The American Association of Immunologists

    Dr Cinzia Volonté

  53. Plasticity of primary microglia on micropatterned geometries and spontaneous long-distance migration in microfluidic channels

    Article • BMC Neuroscience, January 2013, Springer Science + Business Media

    Dr Cinzia Volonté

  54. Metabotropic Purinergic Receptors in Lipid Membrane Microdomains

    Article • Current Medicinal Chemistry, December 2012, Bentham Science Publishers

    Dr Cinzia Volonté

  55. Metabotropic Purinergic Receptors in Lipid Membrane Microdomains

    Article • Current Medicinal Chemistry, December 2012, Bentham Science Publishers

    Dr Cinzia Volonté

  56. Editorial [Pharmacology and Therapeutic Activity of Purinergic Drugs for Disorders of the Nervous System]

    Article • CNS & Neurological Disorders - Drug Targets, October 2012, Bentham Science Publishers

    Dr Cinzia Volonté

  57. P2X7 Receptors: Channels, Pores and More

    Article • CNS & Neurological Disorders - Drug Targets, October 2012, Bentham Science Publishers

    Dr Cinzia Volonté

  58. Purinergic Signalling: What is Missing and Needed Next? The Use of Transgenic Mice, Crystallographic Analysis and MicroRNA

    Article • CNS & Neurological Disorders - Drug Targets, October 2012, Bentham Science Publishers

    Dr Cinzia Volonté

  59. ALS: Focus on purinergic signalling

    Article • Pharmacology & Therapeutics, October 2011, Elsevier

    Dr Cinzia Volonté

  60. Commentary [ Research Highlights(To miR or Not to miR: That is the Question in ALS Disease ]

    Article • CNS & Neurological Disorders - Drug Targets, September 2011, Bentham Science Publishers

    Dr Cinzia Volonté

  61. Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis

    Article • Journal of Neurochemistry, January 2011, Wiley

    Dr Cinzia Volonté

  62. N-Glycans mutations rule oligomeric assembly and functional expression of P2X3 receptor for extracellular ATP

    Article • Glycobiology, December 2010, Oxford University Press (OUP)

    Dr Cinzia Volonté

  63. UDP exerts cytostatic and cytotoxic actions in human neuroblastoma SH-SY5Y cells over-expressing P2Y6 receptor

    Article • Neurochemistry International, April 2010, Elsevier

    Dr Cinzia Volonté

  64. Effects of Acute Perinatal Asphyxia in the Rat Hippocampus

    Article • Cellular and Molecular Neurobiology, January 2010, Springer Science + Business Media

    Dr Cinzia Volonté

  65. P2Y12 Receptor Protein in Cortical Gray Matter Lesions in Multiple Sclerosis

    Article • Cerebral Cortex, September 2009, Oxford University Press (OUP)

    Dr Cinzia Volonté

  66. The Proinflammatory Action of Microglial P2 Receptors Is Enhanced in SOD1 Models for Amyotrophic Lateral Sclerosis

    Article • The Journal of Immunology, September 2009, The American Association of Immunologists

    Dr Cinzia Volonté

  67. Rapid constitutive and ligand-activated endocytic trafficking of P2X3receptor

    Article • Journal of Neurochemistry, May 2009, Wiley

    Dr Cinzia Volonté

  68. A Model of Ischemia-Induced Neuroblast Activation in the Adult Subventricular Zone

    Article • PLoS ONE, April 2009, PLOS

    Dr Cinzia Volonté

  69. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters

    Article • FEBS Journal, December 2008, Wiley

    Dr Cinzia Volonté

  70. Membrane compartments and purinergic signalling

    Article • FEBS Journal, December 2008, Wiley

    Dr Cinzia Volonté

  71. Receptor webs: Can the chunking theory tell us more about it?

    Article • Brain Research Reviews, November 2008, Elsevier

    Dr Cinzia Volonté

  72. Protein cooperation: From neurons to networks

    Article • Progress in Neurobiology, October 2008, Elsevier

    Dr Cinzia Volonté

  73. Do ATP and NO interact in the CNS?

    Article • Progress in Neurobiology, January 2008, Elsevier

    Dr Cinzia Volonté

  74. Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: An immunohistological study

    Article • Purinergic Signalling, September 2007, Springer Science + Business Media

    Dr Cinzia Volonté

  75. P2 Receptor Antagonist Trinitrophenyl-Adenosine-Triphosphate Protects Hippocampus from Oxygen and Glucose Deprivation Cell Death

    Article • Journal of Pharmacology and Experimental Therapeutics, July 2007, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Cinzia Volonté

  76. Comparative analysis of P2Y4 and P2Y6 receptor architecture in native and transfected neuronal systems

    Article • Biochimica et Biophysica Acta (BBA) - Biomembranes, June 2007, Elsevier

    Dr Cinzia Volonté

  77. Extracellular adenosine triphosphate induces glutamate transporter-1 expression in hippocampus

    Article • Hippocampus, January 2007, Wiley

    Dr Cinzia Volonté

  78. P2Y1 receptor switches to neurons from glia in juvenile versus neonatal rat cerebellar cortex

    Article • BMC Developmental Biology, January 2007, Springer Science + Business Media

    Dr Cinzia Volonté

  79. A novel pathway of cell growth regulation mediated by a PLA2 -derived phosphoinositide metabolite

    Article • The FASEB Journal, December 2006, Federation of American Societies For Experimental Biology (FASEB)

    Dr Cinzia Volonté

  80. A Purine Analog-Sensitive Protein Kinase Activity Associates with Trk Nerve Growth Factor Receptors

    Article • Journal of Neurochemistry, October 2006, Wiley

    Dr Cinzia Volonté

  81. P2 receptor web: Complexity and fine-tuning

    Article • Pharmacology & Therapeutics, October 2006, Elsevier

    Dr Cinzia Volonté

  82. The P2Y4 receptor forms homo-oligomeric complexes in several CNS and PNS neuronal cells

    Article • Purinergic Signalling, September 2006, Springer Science + Business Media

    Dr Cinzia Volonté

  83. P2X7 Receptor Modulation on Microglial Cells and Reduction of Brain Infarct Caused by Middle Cerebral Artery Occlusion in Rat

    Article • Journal of Cerebral Blood Flow & Metabolism, January 2006, SAGE Publications

    Dr Cinzia Volonté

  84. Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain

    Article • Neuroscience, January 2006, Elsevier

    Dr Cinzia Volonté

  85. P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFα and potential role in myocardial cell death

    Article • Journal of Molecular and Cellular Cardiology, December 2005, Elsevier

    Dr Cinzia Volonté

  86. Differences in the neurotoxicity profile induced by ATP and ATPγS in cultured cerebellar granule neurons

    Article • Neurochemistry International, October 2005, Elsevier

    Dr Cinzia Volonté

  87. ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: involvement of metabotropic P2 receptors

    Article • Brain Research Reviews, April 2005, Elsevier

    Dr Cinzia Volonté

  88. Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia

    Article • Brain Research Reviews, April 2005, Elsevier

    Dr Cinzia Volonté

  89. The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells

    Article • Neurobiology of Disease, February 2005, Elsevier

    Dr Cinzia Volonté

  90. Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development

    Article • Glia, January 2005, Wiley

    Dr Cinzia Volonté

  91. Role of the metabotropic P2Y4 receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor

    Article • Experimental Cell Research, October 2004, Elsevier

    Dr Cinzia Volonté

  92. P2X3receptor localizes into lipid rafts in neuronal cells

    Article • Journal of Neuroscience Research, April 2004, Wiley

    Dr Cinzia Volonté

  93. Synaptic P2X7 and Oxygen/Glucose Deprivation in Organotypic Hippocampal Cultures

    Article • Journal of Cerebral Blood Flow & Metabolism, April 2004, SAGE Publications

    Dr Cinzia Volonté

  94. 2-ClATP exerts anti-tumoural actions not mediated by P2 receptors in neuronal and glial cell lines

    Article • Biochemical Pharmacology, February 2004, Elsevier

    Dr Cinzia Volonté

  95. Overexpression of superoxide dismutase 1 protects against β-amyloid peptide toxicity: effect of estrogen and copper chelators

    Article • Neurochemistry International, January 2004, Elsevier

    Dr Fulvio Celsi, Dr Cinzia Volonté

  96. Pathways of survival induced by NGF and extracellular ATP after growth factor deprivation

    Article • January 2004, Elsevier

    Dr Cinzia Volonté

  97. Extracellular ATP and Neurodegeneration

    Article • Current Drug Targets - CNS & Neurological Disorders, December 2003, Bentham Science Publishers

    Dr Cinzia Volonté

  98. Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors

    Article • Glia, September 2003, Wiley

    Dr Cinzia Volonté

  99. Up-regulation of p2x2, p2x4 receptor and ischemic cell death: prevention by p2 antagonists

    Article • Neuroscience, August 2003, Elsevier

    Dr Cinzia Volonté

  100. Cerebellar lesion up-regulates P2X1 and P2X2 purinergic receptors in precerebellar nuclei

    Article • Neuroscience, December 2002, Elsevier

    Dr Cinzia Volonté

  101. Identification of an Ectokinase Activity in Cerebellar Granule Primary Neuronal Cultures

    Article • Journal of Neurochemistry, November 2002, Wiley

    Dr Cinzia Volonté

  102. Extracellular ATP and nerve growth factor intensify hypoglycemia-induced cell death in primary neurons: role of P2 and NGFRp75 receptors

    Article • Journal of Neurochemistry, November 2002, Wiley

    Dr Cinzia Volonté

  103. P2 receptor modulation and cytotoxic function in cultured CNS neurons

    Article • Neuropharmacology, March 2002, Elsevier

    Dr Cinzia Volonté

  104. Interaction between ATP and nerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells

    Article • Neuroscience, December 2001, Elsevier

    Dr Cinzia Volonté

  105. Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists

    Article • Neurochemistry International, March 2001, Elsevier

    Dr Cinzia Volonté

  106. Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue

    Article • Neurochemistry International, March 2001, Elsevier

    Dr Cinzia Volonté

  107. Effect of P2 purinoceptor antagonists on kainate-induced currents in rat cultured neurons

    Article • Brain Research, November 2000, Elsevier

    Dr Cinzia Volonté

  108. Antagonists of P2 receptor prevent NGF-dependent neuritogenesis in PC12 cells

    Article • Neuropharmacology, May 2000, Elsevier

    Dr Cinzia Volonté

  109. Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones

    Article • Neuropharmacology, September 1999, Elsevier

    Dr Cinzia Volonté

  110. Characterization of an ecto-phosphorylated protein of cultured cerebellar granule neurons

    Article • Journal of Neuroscience Research, March 1997, Wiley

    Dr Cinzia Volonté

  111. Characterization of an ecto‐phosphorylated protein of cultured cerebellar granule neurons

    Article • Journal of Neuroscience Research, March 1997, Wiley

    Dr Cinzia Volonté

  112. Prevention of Glutamate-Evoked Cytotoxicity

    Article • Emerging Therapeutic Targets, January 1997, Informa Healthcare

    Dr Cinzia Volonté

  113. Biological Effects of P2 Purinoceptor Modulators in Cultured Primary Cerebellar Granule Neurons

    Article • January 1997, Springer Science + Business Media

    Dr Cinzia Volonté

  114. Binding and Functions of Extracellular ATP in Cultured Cerebellar Granule Neurons

    Article • Biochemical and Biophysical Research Communications, August 1996, Elsevier

    Dr Cinzia Volonté

  115. Selected P2 purinoceptor modulators prevent glutamate-evoked cytotoxicity in cultured cerebellar granule neurons

    Article • Journal of Neuroscience Research, July 1996, Wiley

    Dr Cinzia Volonté

  116. Stimulation ofvgfgene expression by NGF is mediated through multiple signal transduction pathways involving protein phosphorylation

    Article • FEBS Letters, February 1995, Wiley

    Dr Cinzia Volonté

  117. Nerve growth factor-activated protein kinase N modulates the cAMP-dependent protein kinase

    Article • Journal of Neuroscience Research, January 1995, Wiley

    Dr Cinzia Volonté

  118. Development of a method for measuring cell number: Application to CNS primary neuronal cultures

    Article • Cytometry, November 1994, Wiley

    Dr Cinzia Volonté

  119. LiCl promotes survival of GABAergic neurons from cerebellum and cerebral cortex: LiCl induces survival of GABAergic neurons

    Article • Neuroscience Letters, May 1994, Elsevier

    Dr Cinzia Volonté

  120. Dexamethasone abolishes the activation by nerve growth factor of protein kinase N: effects of nerve growth factor and dexamethasone on protein kinase N

    Article • Neuroscience Letters, September 1993, Elsevier

    Dr Cinzia Volonté

  121. 6-Methylmercaptopurine Riboside Is a Potent and Selective Inhibitor of Nerve Growth Factor-Activated Protein Kinase N

    Article • Journal of Neurochemistry, February 1992, Wiley

    Dr Cinzia Volonté

  122. Nerve Growth Factor (NGF) Responses by Non-Neuronal Cells: Detection by Assay of a Novel NGF-Activated Protein Kinase

    Article • Growth Factors, January 1990, Taylor & Francis

    Dr Cinzia Volonté

  123. Motility, heat, and lactate production in ejaculated bovine sperm

    Article • Archives of Biochemistry and Biophysics, October 1988, Elsevier

    Dr Cinzia Volonté

  124. Stimulation of Inositol Incorporation into Lipids of PC 12 Cells by Nerve Growth Factor and Bradykinin

    Article • Journal of Neurochemistry, October 1988, Wiley

    Dr Cinzia Volonté

  125. Lithium Stimulation of Membrane-Bound Phospholipase C from PC 12 Cells Exposed to Nerve Growth Factor

    Article • Journal of Neurochemistry, October 1988, Wiley

    Dr Cinzia Volonté

  126. Lithium stimulates the binding of GTP to the membranes of PC12 cells cultured with nerve growth factor

    Article • Neuroscience Letters, April 1988, Elsevier

    Dr Cinzia Volonté

  127. NGF Modulates the Synthesis of a Nuclear Lactic Dehydrogenase with Single-stranded DNA-Binding Properties

    Article • January 1986, Springer Science + Business Media

    Dr Cinzia Volonté